News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2022 Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning Shelley Wood September 19, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
News Conference News TCT 2020 Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves Todd Neale October 17, 2020
News Conference News TCT 2020 Large Databases Hint at Sentinel Benefit During TAVR, but Uncertainty Remains Todd Neale October 16, 2020
News Conference News TCT 2019 MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis Shelley Wood September 29, 2019
News Conference News TCT 2019 Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease Michael O'Riordan September 25, 2019
News Conference News TCT 2018 Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch Lucy Hicks September 26, 2018
Presentation TCT 2014 TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia September 16, 2014
Presentation TCT 2014 Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim September 16, 2014
Presentation TCT 2014 A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Martin B. Leon September 16, 2014
Presentation TCT 2014 Clinical Indications for TAVR: Where are We and Where are We Going? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, A. Pieter Kappetein September 16, 2014